Barbara Castagnari

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

Emilio Iannitto, Monica Bellei, Sandy Amorim et al. · British Journal of Haematology · 2018 · 58 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis et al. · The Lancet Haematology · 2022 · 47 citations

Medicine, Oncology, Pharmacotherapy +12

Soluble urokinase‐type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra‐bone marrow involvement in multiple myeloma patients

Gian Matteo Rigolin, Alessia Tieghi, Maria Ciccone et al. · British Journal of Haematology · 2003 · 44 citations · Full text

Medicine, Cell Biology, Oncology +14

Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells

Francesco Lanza, A Latorraca, Sabrina Moretti et al. · Cytometry · 1997 · 43 citations · Full text

Medicine, Cell Biology, Hematology +14

Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells

Francesco Lanza, Barbara Castagnari, Gian Matteo Rigolin et al. · Leukemia · 1997 · 41 citations · Full text

Medicine, Hematology, Oncology +10